BLOG.

}} BLOG

Urine Alkalization Enhances Gout Management Beyond Uric Acid Control

Urine Alkalization Enhances Gout Management Beyond Uric Acid Control Rheumatology- Oxford Academic Journal, Published  a prospective cohort study that investigated whether adding urine alkalization to urate-lowering therapy (ULT) improves outcomes in men with gout and low urinary pH (<6.2).A total of 385 participants initiating febuxostat therapy were divided into...

Lire la suite...

Urine pH and Kidney Disease

Urine pH and Kidney Disease In this video, Santa Barbara Nutrients President and UCSB Professor Thomas Weimbs, PhD, discusses how to measure urinary pH, why it’s important for individuals with kidney disease to monitor their urinary pH, and the effects of diet on urinary pH. Santa...

Lire la suite...

Reducing Dietary Phosphorus Additives Lowers FGF23 and PTH in Adults with CKD

Reducing Dietary Phosphorus Additives Lowers FGF23 and PTH in Adults with CKD   Published in the Clinical Journal of the American Society of Nephrology (CJASN), this controlled feeding study examined how cutting phosphorus additives in the diet affects mineral metabolism in 50 adults with and without CKD .After two weeks on a...

Lire la suite...

Gut Microbiome Changes May Drive Disease Progression and Early Hypertension in ADPKD

Gut Microbiome Changes May Drive Disease Progression and Early Hypertension in ADPKD This cross-sectional pilot study published in Kidney360, examined the gut microbiome of 25 patients with autosomal dominant polycystic kidney disease (ADPKD) and 12 matched healthy controls.Using 16S rRNA sequencing and serum toxin analysis, the study found that patients with ADPKD...

Lire la suite...

Lower BMI Linked to Slower Progression to Kidney Failure in ADPKD: Insights from the US and Japan

Lower BMI Linked to Slower Progression to Kidney Failure in ADPKD: Insights from the US and Japan NIH National Library of Medicine published a study that examined the relationship between body mass index (BMI) and age at initiation of renal replacement therapy (RRT) in 3,556 patients with autosomal dominant polycystic kidney disease (ADPKD) from two national registries,...

Lire la suite...